Clinical symptoms and videourodynamic findings of detrusor overactivity in women  by Jiang, Yuan-Hong et al.
at SciVerse ScienceDirect
Urological Science 22 (2011) 116e119Contents lists availableUrological Science
journal homepage: www.urol-sci .comOriginal article
Clinical symptoms and videourodynamic ﬁndings of detrusor overactivity in
women
Yuan-Hong Jiang, Qian-Sheng Ke, Hann-Chorng Kuo*
Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwana r t i c l e i n f o
Article history:
Received 16 April 2011
Received in revised form
12 May 2011
Accepted 8 June 2011
Available online 22 September 2011
Keywords:
bladder outlet obstruction
lower urinary tract symptoms
videourodynamics
women* Corresponding author. Department of Urology,
Hospital, 707 Chung-Yang Road, Sec. 3, Hualien 970,
E-mail address: hck@tzuchi.com.tw (H.-C. Kuo).
1879-5226 Copyright  2011, Taiwan Urological Asso
doi:10.1016/j.urols.2011.08.006a b s t r a c t
Objective: Detrusor overactivity (DO) is a urodynamic term for uninhibited detrusor contractions, which
occur in the bladder-ﬁlling phase. Women with urodynamic DO might have different clinical presenta-
tions and pathophysiology involving the bladder, urethra, and pelvic ﬂoor. This retrospective study used
videourodynamic study (VUDS) to analyze the correlation between clinical symptoms and DO subtypes
in women.
Materials and Methods: The records of 526 consecutive women with urodynamic DO who underwent
VUDS for lower urinary tract symptoms (LUTS) from 1996 to 2009 were included. LUTS were classiﬁed as
storage, emptying, pain, and postmicturition symptoms. A ﬁnal diagnosis was made based on VUDS
ﬁndings. Patients were stratiﬁed into the categories idiopathic DO only, DO with inadequate contractility
(DHIC), and DO with bladder outlet obstruction (BOO). The main symptoms and associated symptoms
were used to analyze the correlation with DO subgroups. A group of 272 women with LUTS who were
urodynamically normal served as the symptomatic controls.
Results: Among women with DO, 308 (58.6%) had idiopathic DO only, 69 (13.1%) had DHIC, and 149
(28.3%) had BOO. All of the women in the DO subgroups had storage symptoms as the main or associated
symptoms. A combination of storage and emptying symptoms were more common in patients with DHIC
[49 (71%)] and BOO [77 (51.7%)]. According to the reported storage symptoms in all women, urodynamic
DO was detected in 504 (65.5%) of 770 with frequency symptoms, 467 (73.3%) of 637 with urgency
symptoms, and 293 (87.5%) of 335 with urgency urinary incontinence.
Conclusion: Storage and emptying symptoms are common in women with different DO subtypes.
Differential diagnosis of the DO subtype in women should not be based on LUTS alone.
Copyright  2011, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
It is difﬁcult to make a diagnosis of female lower urinary tract
dysfunction (LUTD) based on lower urinary tract symptoms (LUTS)
alone. Previous studies of female LUTS focused on overactive
bladder (OAB) syndrome, because of its high prevalence.1 Urgency
is the core symptom of OAB, which is deﬁned as a bladder storage
symptom characterized by a sudden, compelling desire to pass
urine that is difﬁcult to defer.2 Patients with OAB symptoms may
have urodynamic detrusor overactivity (DO) characterized by
involuntary detrusor contractions occurring during bladder ﬁlling
or when reaching bladder capacity.
DO in women may be due to neuropathy, or it may be idio-
pathic.2 Some women with idiopathic DO (IDO) may have bladder
outlet obstruction (BOO) or DO with inadequate contractilityBuddhist Tzu Chi General
Taiwan.
ciation. Published by Elsevier Taiw(DHIC) causing incomplete bladder emptying that results in chronic
urinary retention or recurrent urinary tract infections.3,4 Women
with different DO subtypes might also have heterogeneous
symptom presentation.
A videourodynamic study (VUDS) provides comprehensive
investigation of LUTD by combining pressure, uroﬂow, and imaging
studies. In addition to identifying bladder disorders, VUDS can be
used to identify bladder neck dysfunction, dysfunctional voiding,
and urethral stricture.4e6
This retrospective study analyzed VUDS data from a large cohort
of neurologically intact women with urodynamically proven DO to
evaluate the correlation between clinical symptoms and the
underlying DO subtypes.
2. Materials and methods
The charts of 526 consecutive womenwith urodynamic DOwho
had undergone VUDS for LUTS for the ﬁrst time from 1996 to 2009
were included in this retrospective analysis. Patients with chronican LLC. Open access under CC BY-NC-ND license.
Table 1
Main symptoms of female lower urinary tract dysfunction
Symptomatic control,
n (%) (n ¼ 272)
IDO, n (%)
(n ¼ 308)
DHIC, n (%)
(n ¼ 69)
BOO, n (%)
(n ¼ 149)
Storage 159 (58.3) 250 (81.2) 27 (39.1) 93 (62.4)
Emptying 60 (22.1) 58 (18.8) 38 (55.1) 55 (36.9)
Pain 53 (19.6) d 4 (5.8) 1 (1.7)
p ¼ 0.000. BOO ¼ detrusor overactivity with bladder outlet obstruction;
DHIC ¼ detrusor overactivity with impaired contractility; IDO ¼ idiopathic detrusor
overactivity only.
Table 2
Combinations of different lower urinary tract symptoms in female patients with
detrusor overactivity
Symptomatic
control, n (%)
(n ¼ 272)
IDO, n (%)
(n ¼ 308)
DHIC, n
(%) (n ¼ 69)
BOO, n (%)
(n ¼ 149)
Storage alone 96 (35.3) 174 (56.5) 13 (18.8) 51 (34.2)
Emptying alone 1 (0.4) d d d
Storage and emptying 97 (35.7) 112 (36.4) 49 (71.0) 77 (51.7)
Storage and pain 63 (23.2) 20 (6.5) 1 (1.4) 20 (13.4)
Storage, emptying,
and pain
15 (5.5) 2 (0.6) 6 (8.7) 1 (0.7)
BOO ¼ detrusor overactivity with bladder outlet obstruction; DHIC ¼ detrusor
overactivity with impaired contractility; IDO ¼ idiopathic detrusor overactivity
only.
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urinary incontinence, pelvic organ prolapse, possible neurogenic
voiding dysfunction, previous lower urinary tract surgery, or
a previously established diagnosis of interstitial cystitis/painful
bladder syndrome or genitourinary tract malignancy were
excluded from the analysis.
LUTS were carefully recorded. The main symptom was deﬁned
as the most bothersome symptom among all LUTS. Three other
LUTS were also recorded as associated symptoms. LUTS were
classiﬁed as storage symptoms (frequency, urgency, urge urinary
incontinence [UUI], and nocturia), emptying symptoms (dysuria,
hesitancy, slow stream, intermittency, straining to void, and urinary
retention), pain symptoms (bladder pain, urethral pain, and peri-
neal pain), and postmicturition symptoms (terminal dribble, feeling
of incomplete emptying, and postmicturition leakage). Methods,
deﬁnitions, and units conformed to the standards jointly recom-
mended by the International Continence Society and the Interna-
tional Urogynecological Association, except where speciﬁcally
noted.7
VUDS was performed before any treatment was given, using
a multichannel urodynamic system and a C-arm ﬂuoroscope. With
the patient in the supine position, a 6-Fr dual-channel urethral
catheter was inserted transurethrally to record intravesical pres-
sure, and an 8-Fr rectal balloon catheter was used to record the
intra-abdominal pressure. Warm (approximately 30C) normal
saline containing 20% sodium amidotrizoate/meglumine amido-
trizoate was infused at a ﬁlling rate of 30 mL/minute in the sitting
position. A C-arm ﬂuoroscope was positioned 45 degrees from the
buttocks so that the urethra could be lengthened, and the bladder
neck, urethral sphincter, and distal urethra could be clearly iden-
tiﬁed. VUDS was repeated if abnormal ﬁndings were observed
during the ﬁrst examination.
DO was deﬁned as urodynamic evidence of spontaneous
detrusor contractions occurring during bladder ﬁlling (phasic DO)
or occurring before uninhibited detrusor contraction voiding at
bladder capacity (terminal DO).7 Terminal DO was deﬁned by
observing a single involuntary detrusor contraction in the terminal
phase of cystometry. Some patients had both phasic and terminal
DO. If DO was associated with incomplete bladder emptying with
a postvoid residual (PVR) of >100 mL, DHIC was assigned as the
subtype.3 A voiding detrusor pressure of >35 cmH2O was deﬁned
as high voiding pressure. If VUDS showed a narrow bladder outlet
at the bladder neck, urethral sphincter, or distal urethra in associ-
ation with a high voiding pressure and a low ﬂow rate (deﬁned as
a maximum ﬂow rate [Qmax] of <15 cmH2O), BOO was assigned as
the subtype.6 Patients with urodynamic DO without BOO or DHIC
were considered to have IDO.
The ﬁnal diagnosis of LUTD was made based on the main VUDS
ﬁndings and clinical characteristics. According to the VUDS results,
patients were stratiﬁed into three DO subtypes: IDO, DHIC, and
BOO. The main symptoms and a maximum of three associated
symptoms were used for the analysis of their association with DO
subtypes. Urodynamic parameters including cystometric bladder
capacity (CBC), voiding detrusor pressure, Qmax, PVR, and bladder
compliance were analyzed and compared among all DO subgroups.
Statistical analysis was performed by analysis of variance among
different subgroups and Scheffe’s method was used for post hoc
analysis. A p value of <0.05 was considered signiﬁcant.
3. Results
There were 308 women with IDO, 69 with DHIC, 149 with BOO,
and 272 with normal urodynamic ﬁndings included in this study.
The mean age was 57 years. No difference in age distribution was
observed among the groups.Table 1 shows the main clinical symptoms in the symptomatic
controls and all DO subgroups. Storage symptoms were the main
symptom in the symptomatic controls and the IDO and BOO
subgroups, whereas emptying symptoms were the most common
complaints of DHIC patients. Overall, combined storage and
emptying symptoms were the most common in the DHIC subgroup
(71.0%), followed by the BOO subgroup (51.7%), but they only
occurred in 36.4% of the IDO subgroup (Table 2). Interestingly, in the
symptomatic control group, 35.3% had storage symptoms, 35.7%
had both storage and emptying symptoms, and 23.2% had pain and
storage symptoms. The symptom of pain occurred at a signiﬁcantly
higher rate in the control group than in the DO subgroup
(p < 0.001).
If we combined all presenting symptoms in these women, all
women had storage symptoms, and a higher percentage of women
with DHIC had emptying symptoms. Among the storage symptoms,
frequency and urgency were the common symptoms in all groups,
while UUI was a more common complaint in the DHIC and IDO
subgroups than BOO (Table 3). According to the reported storage
symptoms in all DO subgroups and the controls, a positive
predictive value for urodynamic DO was detected in 504 (65.5%) of
770 women with frequency symptoms, 467 (73.3%) of 637 with
urgency symptoms, and 293 (87.5%) of 335 with UUI.
The urodynamic parameters in these DO subgroups are shown
in Table 4. Patients with IDO, DHIC, or BOO had a smaller CBC
compared with that in the symptomatic control group (p< 0.0001).
Voiding Pdet was signiﬁcantly higher in patients with BOO
(p < 0.001) and was signiﬁcantly lower in the DHIC subgroup
compared with control group. Qmax was signiﬁcantly lower in all
DO subgroups compared with that in the symptomatic control
group (p < 0.0001). PVR was signiﬁcantly greater in the DHIC and
BOO subgroups than in the IDO subgroup and symptomatic control
group (p< 0.001). Bladder compliance was signiﬁcantly lower in all
DO subgroups than in the symptomatic control group (p < 0.05).
Based on the VUDS ﬁndings, urodynamic DO was present in 116
women with dysfunctional voiding, 18 with bladder neck
dysfunction, and 15 with urethral stricture.
Among the 308 women with IDO, phasic DO was found in 146,
terminal DO in 152, and both phasic and terminal DO in 10. There
Table 3
Occurrence of different lower urinary tract symptoms with different detrusor
overactivity subtypes
Symptomatic
control, n (%)
(n ¼ 272)
IDO, n (%)
(n ¼ 308)
DHIC, n (%)
(n ¼ 69)
BOO, n (%)
(n ¼ 149)
Storage 272 (100) 308 (100) 69 (100) 149 (100)
Frequency 265 (97.4) 306 (99.4) 59 (85.5) 140 (94)
Urgency 170 (62.5) 291 (94.5) 43 (62.3) 133 (89.3)
UUI 42 (15.4) 185 (60.1) 50 (72.5) 58 (38.9)
Emptying 100 (36.8) 111 (36.0) 55 (79.7) 87 (58.4)
Pain 78 (28.7) 22 (7.1) 7 (10.1) 27 (18.1)
Postmicturition 22 (8.1) 4 (1.3) 1 (1.5) 5 (3.0)
p ¼ 0.000. BOO ¼ detrusor overactivity with bladder outlet obstruction;
DHIC ¼ detrusor overactivity with impaired contractility; IDO ¼ idiopathic detrusor
overactivity only; UUI ¼ urinary urge incontinence.
Table 5
Comparison of urodynamic variables and the main and overall symptom presen-
tation between phasic and terminal detrusor overactivity subtypes
Phasic DOa
(n ¼ 146)
Terminal DO
(n ¼ 152)
p
Urodynamic variable
CBC (mL) 242.5 254.81 0.857
Pdet (cmH2O) 23.22 21.14 0.541
Qmax (mL/s) 13.75 13.12 0.376
PVR (mL) 42.43 41.89 0.455
Compliance 57.76 70.91 0.419
Main symptom
Storage 123 (84.2) 119 (78.3) 0.265
Emptying 23 (15.8) 33 (21.7) d
Overall symptoms
Storage 85 (58.2) 82 (53.9) 0.910
Storage þ emptying 53 (36.3) 58 (38.2) d
Storage þ pain 7 (4.8) 11 (7.2) d
Storage þ emptying þ pain 1 (0.7) 1 (0.7) d
a Ten patients with both phasic and terminal detrusor overactivity were excluded
from this analysis.
CBC ¼ cystometric bladder capacity; DO ¼ detrusor overactivity; Pdet ¼ detrusor
pressure; PVR ¼ postvoid residual; Qmax ¼ maximum ﬂow rate.
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overall symptom presentation between these phasic and terminal
IDO subtypes (Table 5).
4. Discussion
This study analyzed VUDS-derived data and clinical symptoms
in women with urodynamic DO including IDO, DHIC, and BOO
subgroups. Storage and emptying symptoms were commonly
found in all DO subgroups. According to the ﬁnal VUDS diagnosis,
UUI predicted 87.5% of urodynamic DO cases; however, clinical
symptoms are not likely to be reliable in the differential diagnosis
among IDO, DHIC, and BOO.
Our study revealed that most of the women with urodynamic
DO presented with both storage and emptying symptoms. Because
the bladder capacity of patients in all DO subgroups was signiﬁ-
cantly smaller than that of symptomatic control women, it is
possible that thesewomenwith DO experienced dysuria and a slow
stream during voiding, because of early bladder alertness at a small
volume. Recent studies have speculated that an increased bladder
sensation could be a mild subtype of OAB.8 Most patients with OAB
also have bladder hypersensitivity, suggesting that sensory urgency
might be part of the same spectrum of bladder dysfunction as DO.9
The results of the current study also indicated a possible correlation
between increased bladder sensation and DO.
In the present study, based on clinical symptoms, urodynamic
DO was found in 65.5% of women with frequency symptoms, 73.3%
of womenwith urgency (dry OAB), and in 87.5% of womenwith UUI
(OAB wet). These ﬁndings are comparable with those reported in
previous studies.10,11 Although 58.3% of symptomatic control
women also complained of urgency and frequency as their main
symptoms, those symptoms were likely the result of increased
bladder sensation during ﬁlling rather than DO. This possibility
could also be the reason for the different objective urodynamicTable 4
Urodynamic parameters in the control and different detrusor overactivity subgroups
Symptomatic
control (n ¼ 272)
IDO
(n ¼ 308)
DHIC
(n ¼ 69)
BOO
(n ¼ 149)
CBC (mL) 482.3  100.1 250.9  125a 294.7  110a 247.5  146a
Pdet (cmH2O) 18.8  8.98 22.4  11.3a 12.6  7.1a 54.4  20.6a
Qmax (mL/s) 20.5  7.95 13.5  7.84a 6.3  4.45a 10.2  7.22a
PVR (mL) 25.7  44.0 41.8  69.7 188.3  110a 81.0  115.9a
Compliance 120.5  121.2 63.0  67.1a 62.5  69.7a 50.3  64.0a
Values are mean  SD.
a p < 0.05 compared with the control.
BOO ¼ detrusor overactivity with bladder outlet obstruction; CBC ¼ cystometric
bladder capacity; DHIC ¼ detrusor overactivity with impaired contractility;
IDO ¼ idiopathic detrusor overactivity only; Pdet ¼ detrusor pressure;
PVR ¼ postvoid residual; Qmax ¼ maximum ﬂow rate.ﬁndings between OAB patients with and without DO.12 We previ-
ously found that the severity of urgency is important in identifying
urodynamic DO in a group of patients with OAB.13
The current study also showed that urgency and frequency
were highly prevalent in all DO subgroups as well as in women
without urodynamic DO. However, in this retrospective analysis,
we did not record the urgency severity score to grade the severity
of urgency. Patients usually reported urgency only because they
experienced an early voiding desire without actually feeling that
it was difﬁcult to defer urination. If self-reported urgency is
considered synonymous with OAB, then the prevalence of dry OAB
will be very high in women with LUTD. On the other hand, UUI
might have reﬂected the actual urodynamic DO condition in LUTS
in this study. According to the International Continence Society
deﬁnition, urgency is the primary symptom of OAB syndrome, but
in clinical trials, there are inconsistencies in both the deﬁnition
and assessment of urgency. Therefore, the quantitative assessment
of urgency by diary entry may be the most accurate, reproducible,
and clinically meaningful method available for measuring this
variable.14 A voiding diary with speciﬁc recording of UUI will help
identify true UUI, and therefore, urodynamic DO in women who
report having UUI.13
The CBC of patients with IDO, DHIC, and BOO was similar to and
smaller than that of the symptomatic controls, indicating that
sensory urgency is closely linked to urodynamic DO. This ﬁnding
also reﬂects the possibility that a DO bladder is not only over-
active, but also hypersensitive.15 Although the bladder is consid-
ered an unreliable variable for predicting urodynamic DO,10 it has
been demonstrated that involuntary detrusor contractions occur at
approximately 80% of cystometric capacity, and 81% of neurologi-
cally impaired patients and 97% of neurologically intact patients
were aware of involuntary detrusor contractions at the time of
urodynamic study.16 A careful urodynamic investigation can detect
most involuntary detrusor contractions, and urodynamic DO can
accordingly be diagnosed.
The current study also revealed that clinical symptoms and
urodynamic variables did not differ between phasic and terminal
DO. Recent research suggests that ion-channel abnormalities and
suburothelial interstitial cells may play important roles in sponta-
neous detrusor contractility,17 whereas terminal DO is more likely
to result from neurological lesions such as spinal cord injury or
central nervous system degenerative diseases.18,19 Patients with
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timed voiding, sometimes combined with anticholinergic drugs,
whereas patients with phasic DO are often good candidates for
noninvasive electrical neuromodulation.20 Male patients with
benign prostatic hyperplasia and DO may ignore the symptom of
urgency because of abnormal bladder sensations or because
subconscious sphincter contractions abort the overactivity.21
Therefore, not all patients with IDO have only urgency
complaints. Patients with undetected phasic DO might not expe-
rience urgency and may present with terminal DO and abnormal
bladder sensations.
In the present study, DHIC was the second most common (33%)
cause of incontinence. DHIC may represent a more advanced stage
in the natural history of detrusor hyperreﬂexia, a stage character-
ized by deterioration of detrusor contractile efﬁciency.3 Several
neurological diseases may cause DHIC.22 Geriatric urinary inconti-
nence, especially in combination with reduced bladder sensations,
is associated with speciﬁc cortical abnormalities such as frontal and
global cortical underperfusion and cognitive impairment.23 A
portion of patients with DHIC may present with impaired aware-
ness of the need to void, which probably reﬂects greater brain
damage.24 Although patients with a possible neurogenic lesion
were excluded fromour study, the average age of DHIC patients was
not older than the other subgroups. We speculate that poor relax-
ation of the pelvic ﬂoor muscles causes detrusor underactivity and
that incomplete emptying in addition to occult neuropathy might
contribute to DHIC.6
The present study showed that urodynamic DO in women
involves several different vesicourethral conditions including
sensory, motor, and bladder outlet disorders. Symptoms alone are
not reliable for detecting the underlying DO subtype. VUDS is
a comprehensive examination with which to investigate bladder
and bladder outlet disorders during the ﬁlling and emptying pha-
ses. In women with LUTS, VUDS provides informative data for the
diagnosis of dysfunctional voiding, bladder neck dysfunction, and
urethral stricture. Although a pressure ﬂow study can also differ-
entiate bladder disorders from urethral dysfunction, diagnosis of
bladder outlet disorders of women is difﬁcult to establish without
VUDS.4,6
In our study, we found that clinical presentations of the symp-
tomatic control group were similar to those of the DO subgroups
with a higher rate of bladder pain in the former group. Althoughwe
did not detect any urodynamic DO in the symptomatic control
group, they could not be grouped with the normal controls because
they were affected by LUTS. Pain in nearly 20% of these women
might have been due to urothelial dysfunction or early signs of
a hypersensitive bladder or interstitial cystitis, which the current
study did not analyze.5. Conclusions
Storage and voiding symptoms are common in womenwith any
urodynamic DO subtype. UUI provides a positive predictive value of
87.5% for urodynamic DO. The differential diagnosis of DO subtypes
cannot be based solely on LUTS.References
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